Who
Srishti Gupta
Chief Executive Officer
Company insider
Files Form 4 as: Chief Executive Officer, NovaBridge Biosciences; Director, Invivyd.
In numbers
- Trades disclosed
- 3
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 21 May 2024
- Last trade
- 6 Jul 2026
- Last filed
- 8 Jul 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 6 Jul 2026filed 8 Jul 2026 | NBP NovaBridge Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —3,000,000 at $0.00 | filing |
| 6 Jul 2026filed 8 Jul 2026 | NBP NovaBridge Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —3,000,000 at $0.00 | filing |
| 21 May 2024filed 23 May 2024 | IVVD Invivydoption or derivative · Biotechnology | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.